CLINICAL_TRIALS
research
· 2010-09-14
Clinical Trial Update: Study of the Impact of Hypersplenism and Splenectomy on Hepatocarcinogenesis in Patients With Posthepatitic Cirrhosis
Summary
This clinical trial update describes a study examining how hypersplenism and splenectomy influence hepatocarcinogenesis in patients with posthepatitic cirrhosis…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Xijing Hospital | Conditions: Liver Cirrhosis, Carcinoma, Hepatocellular | Status: UNKNOWN